Blinatumomab in Refractory Myasthenia Gravis (BLINA-MG)

Clinical trial NCT06684184 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06684184
Sponsor: Zhongming Qiu
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Myasthaenia Gravis

Start date: 2024-11-30
Primary completion: 2025-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.